One of the requisites is the Trail participant should not have had the vaccination. Looking at that rate of the vaccination drive, I think more than 100 million people have received a Covid shot in America. ResApp trial might take a bit longer due to this eligibility criterion. Just my opinion.
I am keener on hearing something about the Medgate trials on ResApps core product i.e ResApp-DX. That's a bedrock feature of this company and that's where the value proposition lies ( for now). I eagerly ( read patiently) wait to see how this pans out and articulated to the wider community.
COVID detection can be a good verticle, but I won't put too much weight on it, just yet.
I think the ResApp fleet should have all hands on deck to get the validated product-ResApp DX -up and running.
"A bird in the hand is better than 2 in a bush"
June 2021 seems to be a pivot month where things might get more interesting.
IMO
- Forums
- ASX - By Stock
- Ann: Medgate commences European ResAppDx trial
One of the requisites is the Trail participant should not have...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online